RAPP
Rapport Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$27.84
-0.83 ▼ -2.90%
🌙 3월 13일 4:20 PM ET (한국 3/14 05:20)
$27.84
+0.00 +0.00%
| Index | RUT | P/E | - | EPS (ttm) | -2.87 | Insider Own | 38.7% | Shs Outstand | 0.05B | Perf Week | -7.94% |
| Market Cap | 1.33B | Forward P/E | - | EPS next Y | -25.71% | Insider Trans | -0.73% | Shs Float | 0.03B | Perf Month | 0.72% |
| Enterprise Value | 0.85B | PEG | - | EPS next Q | -0.59 | Inst Own | 73.04% | Short Float | 11.99% | Perf Quarter | -2.9% |
| Income | -0.11B | P/S | - | EPS this Y | -17.06% | Inst Trans | 4.6% | Short Ratio | 9.57 | Perf Half Y | 20% |
| Sales | 0.00B | P/B | 2.74 | EPS next 5Y | -18.56% | ROA | -26.95% | Short Interest | 3.51M | Perf YTD | -8.24% |
| Book/sh | 10.15 | P/C | 2.71 | EPS past 3/5Y | -114.24% - | ROE | -28.22% | 52W High | -34.14% ($42.27) | Perf Year | 177.84% |
| Cash/sh | 10.27 | P/FCF | - | Sales past 3/5Y | - | ROIC | -22.6% | 52W Low | 260.16% ($7.73) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -33.82% | Gross Margin | - | Volatility(W/M) | 9.88% 8.33% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 2.27 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 26.17 | EPS Q/Q | -31.58% | Profit Margin | - | RSI (14) | 44.82 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 26.17 | Sales Q/Q | - | SMA20 | -5.06% ($29.32) | Beta | 1.49 | Target Price | $53.25 |
| Payout | - | Debt/Eq | 0.02 | Earnings | 3000000 | SMA50 | -1.2% ($28.18) | Rel Volume | 1.09 | Prev Close | $28.67 |
| Employees | 84 | LT Debt/Eq | 0.02 | EPS/Sales Surpr. | -6.27% - | SMA200 | 22.33% ($22.76) | Avg Volume(3M) | 0.37M | Price | $27.84 |
| IPO | 2024/6/7 | Option/Short | Yes/Yes | Trades | 6104 | Volume | 401,236 | Change | -2.9% |
뉴스 로딩 중...